Results 251 to 260 of about 425,528 (280)
Correction: FGFR3-TACC3 fusion gene promotes glioblastoma malignant progression through the activation of STAT3 signaling pathway. [PDF]
Front OncolLi Y +8 more
europepmc +1 more source
Retraction: ARHGAP24 inhibits cell cycle progression, induces apoptosis and suppresses invasion in renal cell carcinoma. [PDF]
OncotargetXu G, Lu X, Huang T, Fan J.
europepmc +1 more source
Scandinavian Journal of Surgery, 2004 RENAL CELL CARCINOMA (RCC) accounts for approximately 3% of adult malignancy and 90% to 95% of neoplasms arising from the kidney. It is the sixth leading cause of cancer death in the United States. Approximately 31200 new cases of RCC were diagnosed in the United States in 2000 and more than 11900 affected individuals died.
Mirja Ruutu, Börje Ljungberg
+8 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Oncology, 2005
This review focuses on recent developments in the biology and clinical therapeutics of renal cell carcinoma. Given historically limited advances in this disease, a more thorough understanding and testing of rationally targeted agents is needed.Von Hippel-Lindau gene inactivation is observed in most clear cell renal carcinoma, driving the malignant ...
Brian I, Rini +2 more
openaire +6 more sources
This review focuses on recent developments in the biology and clinical therapeutics of renal cell carcinoma. Given historically limited advances in this disease, a more thorough understanding and testing of rationally targeted agents is needed.Von Hippel-Lindau gene inactivation is observed in most clear cell renal carcinoma, driving the malignant ...
Brian I, Rini +2 more
openaire +6 more sources